India revokes patent of Novartis’ cardiac drug
NEW DELHI: The Indian Patent Office (IPO) has revoked the patent on Novartis' cardiac blockbuster drug Vymada on grounds of...
NEW DELHI: The Indian Patent Office (IPO) has revoked the patent on Novartis' cardiac blockbuster drug Vymada on grounds of...
NEW DELHI: A clutch of global private equity (PE) players are eyeing a minority stake in Romsons Group, a medical...
NEW DELHI: With traditional multi-specialty hospital chains nearing deal saturation, investors are increasingly shifting their focus on single-specialty hospitals (SSHs),...